Showing results (111-120 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|May 4, 2018
Sample size determination and treatment screening in two-stage phase II clinical trials via ROC curveWong-Shian Huang, Yuan-Chin Ivan ChangPharmaceutical Statistics|April 28, 2018
Optimal planning of phase II/III programs for clinical trials with multiple endpointsMeinhard Kieser, Marietta Kirchner, Eva Dölger, et al.Pharmaceutical Statistics|January 31, 2009
Inference on treatment effects for targeted clinical trials under enrichment designJen-Pei Liu, Jr-Rung Lin, Shein-Chung ChowPharmaceutical Statistics|October 20, 2007
Accounting for variability in individual hierarchical clinical trial dataFabián Tibaldi, Didier Renard, Geert MolenberghsPharmaceutical Statistics|October 25, 2007
Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSISue-Jane WangPharmaceutical Statistics|August 4, 2007
Multiplicity and flexibility in clinical trialsWerner Brannath, Franz Koenig, Peter BauerPharmaceutical Statistics|February 27, 2007
Optimal design of clinical trials comparing several treatments with a controlIan C MarschnerPharmaceutical Statistics|February 27, 2007
Graphical approaches to the analysis of safety data from clinical trialsOhad Amit, Richard M Heiberger, Peter W LanePharmaceutical Statistics|March 17, 2007
Retracted and replaced: Sodium cromoglicate: an ineffective drug or meta-analysis misused?M T Stevens, A M Edwards, J B L HowellPharmaceutical Statistics|November 28, 2006
A note on the power of Fisher's least significant difference procedureUlrich MeierPageof 119